ZHANGJIANG ATTRACTS THE WORLD'S R&D.

The article focuses on research and development (R&D) facilities at the Zhangjiang Hi-Tech Park in Shanghai, China which became a suitable location for chemical companies including AstraZeneca, GlaxoSmithKline and Novasep. It states that majority of the drug multinational companies in the industrial park never laid off employees despite of rising cost of doing business. The industrial park has a tram service for its employees.